Boehringer Ingelheim enters global licensing agreement to develop and commercialise antibodies from…
This partnership allows Boehringer Ingelheim to strengthen its tumour cell-directed Antibody-Drug Conjugate (ADC) and immune…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.